WFL logo

Wellfully Limited Stock Price

ASX:WFL Community·AU$1.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

WFL Share Price Performance

AU$0
0.00 (0.00%)
AU$0
0.00 (0.00%)
Price AU$0

WFL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium and slightly overvalued.

6 Risks
0 Rewards

Wellfully Limited Key Details

AU$1.7m

Revenue

AU$1.9m

Cost of Revenue

-AU$200.4k

Gross Profit

AU$7.6m

Other Expenses

-AU$7.8m

Earnings

Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
-0.016
-12.05%
-469.00%
-98.7%
View Full Analysis

About WFL

Founded
1992
Employees
n/a
CEO
Paul Peros
WebsiteView website
www.wellfully.net

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Perth, Australia.

Recent WFL News & Updates

Recent updates

No updates